Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Design and recruitment for retinoid skin cancer prevention (SKICAP) trials. The Southwest Skin Cancer Prevention Study Group.

Moon TE, Levine N, Cartmel B, Bangert J, Rodney S, Schreiber M, Peng YM, Ritenbaugh C, Meyskens F, Alberts D.

Cancer Epidemiol Biomarkers Prev. 1995 Sep;4(6):661-9.

2.

Retinoids in prevention of skin cancer.

Moon TE, Levine N, Cartmel B, Bangert JL.

Cancer Lett. 1997 Mar 19;114(1-2):203-5.

PMID:
9103292
3.

Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.

Levine N, Moon TE, Cartmel B, Bangert JL, Rodney S, Dong Q, Peng YM, Alberts DS.

Cancer Epidemiol Biomarkers Prev. 1997 Nov;6(11):957-61.

4.

Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.

Moon TE, Levine N, Cartmel B, Bangert JL, Rodney S, Dong Q, Peng YM, Alberts DS.

Cancer Epidemiol Biomarkers Prev. 1997 Nov;6(11):949-56.

5.

Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group.

Karagas MR, McDonald JA, Greenberg ER, Stukel TA, Weiss JE, Baron JA, Stevens MM.

J Natl Cancer Inst. 1996 Dec 18;88(24):1848-53.

PMID:
8961975
6.

Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.

Karagas MR, Greenberg ER, Mott LA, Baron JA, Ernster VL.

Cancer Epidemiol Biomarkers Prev. 1998 Feb;7(2):157-61.

7.

Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.

Christian JB, Lapane KL, Hume AL, Eaton CB, Weinstock MA; VATTC Trial.

J Natl Cancer Inst. 2008 Sep 3;100(17):1223-32. doi: 10.1093/jnci/djn262. Epub 2008 Aug 26.

PMID:
18728281
8.

Isotretinoin-basal cell carcinoma prevention trial. Design, recruitment results, and baseline characteristics of the trial participants. The ISO-BCC Study Group.

Tangrea J, Edwards B, Hartman A, Taylor P, Peck G, Salasche S, Menon P, Winton G, Mellette R, Guill M, et al.

Control Clin Trials. 1990 Dec;11(6):433-50.

PMID:
1963135
9.

Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.

Tschen EH, Wong DS, Pariser DM, Dunlap FE, Houlihan A, Ferdon MB; Phase IV ALA-PDT Actinic Keratosis Study Group.

Br J Dermatol. 2006 Dec;155(6):1262-9.

PMID:
17107399
10.

A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in the physician's health study.

Frieling UM, Schaumberg DA, Kupper TS, Muntwyler J, Hennekens CH.

Arch Dermatol. 2000 Feb;136(2):179-84.

PMID:
10677093
11.

Increased effectiveness of targeted skin cancer screening in the Veterans Affairs population of Northern California.

Swetter SM, Waddell BL, Vazquez MD, Khosravi VS.

Prev Med. 2003 Feb;36(2):164-71.

PMID:
12590991
12.
13.

Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.

Elmets CA, Viner JL, Pentland AP, Cantrell W, Lin HY, Bailey H, Kang S, Linden KG, Heffernan M, Duvic M, Richmond E, Elewski BE, Umar A, Bell W, Gordon GB.

J Natl Cancer Inst. 2010 Dec 15;102(24):1835-44. doi: 10.1093/jnci/djq442. Epub 2010 Nov 29.

14.

Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.

Criscione VD, Weinstock MA, Naylor MF, Luque C, Eide MJ, Bingham SF; Department of Veteran Affairs Topical Tretinoin Chemoprevention Trial Group.

Cancer. 2009 Jun 1;115(11):2523-30. doi: 10.1002/cncr.24284.

15.

High sun protection factor sunscreens in the suppression of actinic neoplasia.

Naylor MF, Boyd A, Smith DW, Cameron GS, Hubbard D, Neldner KH.

Arch Dermatol. 1995 Feb;131(2):170-5.

PMID:
7857113
16.

Facial resurfacing for nonmelanoma skin cancer prophylaxis.

Hantash BM, Stewart DB, Cooper ZA, Rehmus WE, Koch RJ, Swetter SM.

Arch Dermatol. 2006 Aug;142(8):976-82.

PMID:
16924046
18.

[Retinoids and the prevention of cutaneous epitheliomas: 1977-1987].

Schnitzler L.

Ann Dermatol Venereol. 1987;114(12):1537-43. French.

PMID:
3445984
19.

The Nambour Skin Cancer and Actinic Eye Disease Prevention Trial: design and baseline characteristics of participants.

Green A, Battistutta D, Hart V, Leslie D, Marks G, Williams G, Gaffney P, Parsons P, Hirst L, Frost C, et al.

Control Clin Trials. 1994 Dec;15(6):512-22.

PMID:
7851112
20.

Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study.

Harwood CA, Leedham-Green M, Leigh IM, Proby CM.

Arch Dermatol. 2005 Apr;141(4):456-64.

PMID:
15837863

Supplemental Content

Support Center